Simpson Curran — SEC Form 4 filings
SEC reporting owner CIK 1346164. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-07-03 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 45,917 shares, $563,204 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 20,811 shares @ $12.62 ($262,635) in REGENXBIO Inc., filed 2025-10-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | Chief Executive Officer, Director | 12 | — | 5 legs · 45,917 sh · $563,204 | 13 |
Form 4 filings — Simpson Curran
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 951 @ $7.00 · Grant/award (A): 1,453 @ $10.18 · Tax withholding (F): 6,818 @ $13.09 | EDGAR |
| 2026-01-08 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 144,864 @ $0 · Grant/award (A): 233,651 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 18,559 @ $14.40 | EDGAR |
| 2025-10-10 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 20,811 @ $12.62 | EDGAR |
| 2025-10-01 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 7,624 @ $10.03 | EDGAR |
| 2025-09-12 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 7,734 @ $10.02 | EDGAR |
| 2025-07-03 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 4,701 @ $8.23 | EDGAR |
| 2025-01-14 | 4/A | REGENXBIO Inc. (RGNX) | Grant/award (A): 478,606 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 11,917 @ $7.73 · Grant/award (A): 98,912 @ $0 · Grant/award (A): 476,606 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 100 @ $15 | EDGAR |
| 2024-07-30 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 9,648 @ $15.04 | EDGAR |
| 2024-07-03 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 56,458 @ $0 · Grant/award (A): 272,189 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1346164 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →